PREPARATION OF BINARY INCLUSION COMPLEX OF RIVAROXABAN WITH BETA CYCLODEXTRIN; PHYSIOCHEMICAL AND SOLID-STATE CHARACTERIZATION
Main Article Content
Keywords
rivaroxaban, β-cyclodextrin, kneading method, dissolution, solubility
Abstract
Low aqueous solubility and erratic bioavailability pattern is the limiting factor to achieve desired therapeutic outcomes from a variety of new and existing drugs. This study was aimed to evaluate the effect of the preparation method on the binary inclusion complex of rivaroxaban (RIV). The inclusion complexes were prepared using four different methods (physical trituration, freeze drying kneading and solvent evaporation) at RIV-cyclodextrins weight molar ratios of 1:1, 1:2 and 1:4. Solubility studies in the presence of βCD was performed to determine the quantitative increase in solubility. Dissolution studies were performed to evaluate the drug release behavior from the binary inclusion complex in the aqueous medium. The inclusion complexes were subjected to characterization of fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), X-ray diffractometry (XRD) and differential scanning calorimetry (DSC). The phase solubility studies confirmed that RIV solubility ameliorated proportionally with an increase in β-CD concentration. FTIR, SEM, XRD and DSC confirmed the successful inclusion of RIV into cyclodextrin (β-CD) cavity. Among the four preparation methods (physical trituration, freeze drying kneading and solvent evaporation) used for the inclusion complexes, kneading is the most suitable method for preparation of RIV: βCD inclusion complex with ameliorated solubility and drug release in aqueous medium.
References
2. Choi, M.-J., et al., Effects of Polymers on the Drug Solubility and Dissolution Enhancement of Poorly Water-Soluble Rivaroxaban. 2022. 23(16): p. 9491.
3. Bai, L., et al., Inclusion complexation, encapsulation interaction and inclusion number in cyclodextrin chemistry. 2009. 253(9-10): p. 1276-1284.
4. Magnúsdóttir, A., et al., The conventional model of drug/cyclodextrin complex formation (salicylic acid/β-cyclodextrin inclusion complex). 2002. 44: p. 213-218.
5. Irie, T. and K.J.J.o.p.s. Uekama, Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. 1997. 86(2): p. 147-162.
6. Saokham, P., et al., Solubility of cyclodextrins and drug/cyclodextrin complexes. 2018. 23(5): p. 1161.
7. Lee, J.-H., et al., The Development and Optimization of Hot-Melt Extruded Amorphous Solid Dispersions Containing Rivaroxaban in Combination with Polymers. 2021. 13(3): p. 344.
8. Sherje, A.P. and M.J.J.o.M.S.M.i.M. Jadhav, β-Cyclodextrin-based inclusion complexes and nanocomposites of rivaroxaban for solubility enhancement. 2018. 29(12): p. 1-8.
9. Higuchi, T.J.A.A.C.I., Connors, Phase-solubility techniques. 1965. 7: p. 117-212.
10. Bashir, M., et al., Binary inclusion complexes of diflunisal with β-cyclodextrin and hydroxypropyl-β-cyclodextrin: Preparation and characterization. 2020. 33.
11. Abouhussein, D.M., D. Bahaa El Din Mahmoud, and E.J.J.o.L.R. Mohammad F, Design of a liquid nano-sized drug delivery system with enhanced solubility of rivaroxaban for venous thromboembolism management in paediatric patients and emergency cases. 2019. 29(4): p. 399-412.
12. Rubim, A.M., et al., Inclusion complex of amiodarone hydrochloride with cyclodextrins: preparation, characterization and dissolution rate evaluation. 2017. 53.
13. Baka, E., et al., Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. 2008. 46(2): p. 335-341.
14. Bocanegra, L., et al., Fluid and particle laser Doppler velocity measurements and mass transfer predictions for the USP paddle method dissolution apparatus. 1990. 16(9): p. 1441-1464.
15. Anderson, N., et al., An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles. 1998. 17(4-5): p. 811-822.
16. Ishtiaq, M., et al., Development of the Amorphous Solid Dispersion of Curcumin: A Rational Selection of Polymers for Enhanced Solubility and Dissolution. 2022. 12(11): p. 1606.
17. Syukri, Y., et al., Preperation and characterization of Β-cyclodextrin inclusion complexes oral tablets containing poorly water soluble glimipiride using freeze drying method. 2015. 26(2): p. 71.
18. Fenyvesi, F., et al., Cyclodextrin complexation improves the solubility and Caco-2 permeability of chrysin. 2020. 13(16): p. 3618.
19. Jacob, S. and A.B.J.D.d.r. Nair, Cyclodextrin complexes: Perspective from drug delivery and formulation. 2018. 79(5): p. 201-217.
20. Had?iabdi?, J., et al., Effect of Cyclodextrin Complexation on the Aqueous Solubility of Diazepam and Nitrazepam: Phase-Solubility Analysis, Thermodynamic Properties %J American Journal of Analytical Chemistry. 2012. Vol.03No.12: p. 9.
21. Baboota, S., M. Dhaliwal, and K.J.A.P. Kohli, Physicochemical characterization, in vitro dissolution behavior, and pharmacodynamic studies of rofecoxib-cyclodextrin inclusion compounds. Preparation and properties of rofecoxib hydroxypropyl β-cyclodextrin inclusion complex: A technical note. 2005. 6(1): p. E83-E90.
22. Soe, H.M.H., et al., The investigation of binary and ternary sulfobutylether-β-cyclodextrin inclusion complexes with asiaticoside in solution and in solid state. 2020. 498: p. 108190.
23. Metre, S., et al., Enhanced biopharmaceutical performance of rivaroxaban through polymeric amorphous solid dispersion. 2018. 15(2): p. 652-668.
24. Semalty, A. and Y. Tanwar, Preparation and characterization of cyclodextrin inclusion complexes for improving solubility and dissolution of nimesulide. World Journal of Pharmaceutical Sciences, 2014. 2: p. 72-78.
25. El-Badry, M., et al., Performance of poloxamer 407 as hydrophilic carrier on the binary mixtures with nimesulide. 2013. 61(6): p. 1137-1150.
26. Prasanthi, N., et al., Effect of poloxamer 188 on in vitro dissolution properties of antipsychotic solid dispersions. 2011. 10(1): p. 15-19.
27. Tănase, I.-M., et al., Physicochemical characterization and molecular modeling study of host–guest systems of aripiprazole and functionalized cyclodextrins. 2020. 141(3): p. 1027-1039.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Waqas Haider Khan
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad 38000, Pakistan.
Ikram Ullah Khan
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad 38000, Pakistan.
Sajid Asghar
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad 38000, Pakistan.
Muhammad Irfan
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad 38000, Pakistan.
Syed Haroon Khalid
PhD, Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University, 38000, Faisalabad, Pakistan. Telephone: 0092-3166752223.